SSTR4 agonist 2

• UNSPSC Description:

  SSTR4 agonist 2 is a potent agonist of somatostatin receptor subtype 4 (SSTR4). SSTR4 pathway inhibits nociceptive and inflammatory processes. SSTR4 agonist 2 has the potential for the research of medical disorders related to SSTR4 (extracted from patent WO2014184275A1, compound 107)[1].

• Target Antigen:

  Somatostatin Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/sstr4-agonist-2.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC(C)(C(C1=CC=C2)=NN(C)C1=C2C)NC([C@H]3[C@@]4([H])[C@]3([H])CNC4)=O

• Molecular Weight:

  312.41

• References & Citations:

  [1]Riccardo Giovannini, et al. New somatostatin receptor subtype 4 (sstr4) agonists. Patent WO2014184275A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1638589-52-2